Literature DB >> 10548258

Preexposure to drug administration context blocks the development of tolerance to sedative effects of diazepam.

R H Marin1, M F Pérez, D G Duero, O A Ramirez.   

Abstract

The development of tolerance to benzodiazepine (BDZ) and other psychoactive agents such as morphine, alcohol, and barbiturates is thought to be a contingent or learning phenomenon. In a previous report, we demonstrated a positive correlation between the development of tolerance to the sedative effects of diazepam (DZ) and hippocampal synaptic plasticity. The results of the present work show that the development of tolerance to the hypolocomotor action of DZ (5 mg/kg) for 4 days and the associated increase in synaptic plasticity are context specific. Because animal preexposure to the drug administration context blocks both the tolerance sedative effects of DZ and the increased hippocampal synaptic plasticity, observed after 4 days of DZ administration, we propose the increased synaptic plasticity on hippocampal development as one of the biological substrates to the tolerance to DZ. Besides, the continuous administration of DZ did not induce a conditioning opponent response in these animals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548258     DOI: 10.1016/s0091-3057(99)00097-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice.

Authors:  Carolien van Rijnsoever; Marcus Täuber; Mohamed Khaled Choulli; Ruth Keist; Uwe Rudolph; Hanns Mohler; Jean Marc Fritschy; Florence Crestani
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

2.  The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.

Authors:  Brittany T Wright; Catherine F Gluszek; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-15       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.